🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)

Found 22 matching trials

Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management

N/A

The purpose of this study is to evaluate whether beclomethasone dipropionat...

Status

Completed

Location

Optimum Patient Care

Start Date

2008-01

Trial ID

NCT01242098

Treatments Being Tested

Fixed dose combination salmeterol / fluticasone Fixed-dose combination beclometasone dipropionate / formoterol

Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)

A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequi...

Status

Completed

Location

West-Ward Research Site #1

Start Date

2018-04-26

Trial ID

NCT03535870

Treatments Being Tested

Fluticasone propionate/salmeterol Advair Diskus, 100 Mcg-50 Mcg Inhalation Powder Placebo

Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients

N/A

This is an observational retrospective analysis of linked pharmacy and medi...

Status

Completed

Location

Multiple Locations

Start Date

2010-10

Trial ID

NCT01431924

Treatments Being Tested

Higher-dose inhaled corticosteroids Low-dose fixed dose fluticasone propionate/salmeterol xinafoate combination

WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects

N/A

Pneumonia remains an important cause of morbidity and mortality in older ad...

Status

Completed

Location

Multiple Locations

Start Date

2012-07

Trial ID

NCT01763463

Treatments Being Tested

New users of ADVAIR DISKUS, ADVAIR HFA (ICS) - containing medications New users of FLOVENT DISKUS, FLVENT HFA (long-acting bronchodilators (LABD))

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

PHASE2

The primary objective of this study is to evaluate the dose response, effic...

Status

Completed

Location

Teva Investigational Site 10453

Start Date

2013-01

Trial ID

NCT01772368

Treatments Being Tested

Fp MDPI FS MDPI Advair Diskus Albuterol

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequi...

Status

Completed

Location

Roxane Laboratories Research Site #30

Start Date

2014-08

Trial ID

NCT02649478

Treatments Being Tested

Fluticasone / Salmeterol Placebo Advair Diskus 100/50

Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs

PHASE1

This is a crossover study to assess the systemic pharmacokinetics of flutic...

Status

Completed

Location

Worldwide Clinical Trials Early Phase Services

Start Date

2013-10

Trial ID

NCT02215122

Treatments Being Tested

MGR001 Advair® Diskus®Seretide™ Accuhaler™

Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)

PHASE3

This study is being conducted to demonstrate the non-inferiority between tw...

Status

Completed

Location

Multiple Locations

Start Date

2007-04

Trial ID

NCT00424008

Treatments Being Tested

Mometasone furoate/formoterol (MF/F) MDI Fluticasone propionate/salmeterol (F/SC) DPI

SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)

PHASE4

An 18 months randomised double-blind study with two parallel arms with star...

Status

Completed

Location

GSK Investigational Site

Start Date

2005-05-03

Trial ID

NCT00455923

Treatments Being Tested

Seretide Flixotide

Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.

PHASE3

This is a multi-centre, randomized, double-blind，placebo parallel-controlle...

Status

Completed

Location

The First Affiliated Hospital of Guangzhou Medical University

Start Date

2018-05-09

Trial ID

NCT03468790

Treatments Being Tested

CMAB007 Symbicort Seretide Ventolin placebo

Previous Next